Absence of Steroid in Renal Transplantation and Digital Fibrosis Observation

PHASE4CompletedINTERVENTIONAL
Enrollment

193

Participants

Timeline

Start Date

April 30, 2012

Primary Completion Date

August 31, 2018

Study Completion Date

August 31, 2018

Conditions
Renal Transplant
Interventions
OTHER

Absence of corticotherapy post-transplantation

No study treatment

DRUG

Corticotherapy post-transplantation

"Prednisone or prednisolone orally for at least one year post-transplantation with the following minimal doses :~* D1 to D14 : 20 mg/day,~* D15 to M1 : 15 mg/day,~* M1 to M3 : 10 mg/day,~* M3 to M12 : 5 mg/day."

Trial Locations (8)

31049

CHU de Toulouse, Toulouse

37044

CHRU de Tours, Tours

42270

CHU de Saint-Etienne, Saint-Etienne

44093

Nantes University Hospital, Nantes

69437

CHU de Lyon, Lyon

75743

AP-HP - Hôpital Necker, Paris

94275

AP-HP - Hôpital Bicêtre, Paris

06000

CHU de Nice, Nice

All Listed Sponsors
lead

Nantes University Hospital

OTHER

NCT01541176 - Absence of Steroid in Renal Transplantation and Digital Fibrosis Observation | Biotech Hunter | Biotech Hunter